v3.26.3
SEGMENT AND ENTERPRISE-WIDE INFORMATION (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Sep. 26, 2026
Sep. 27, 2025
Sep. 26, 2026
Sep. 27, 2025
Mar. 28, 2026
Segment Reporting [Line Items]          
Total net revenues $ 357,759 $ 327,315 $ 697,139 $ 648,709  
Cost of goods sold 136,846 132,571 273,423 261,721  
Selling, general and administrative 118,361 101,615 237,302 212,334  
Research and development 17,029 14,872 33,229 31,133  
Operating income 75,120 58,491 132,578 112,363  
Amortization of acquired assets 10,403 11,182 20,607 22,574  
Interest and other expense, net (12,261) (7,206) (22,145) (15,909)  
Income before provision for income taxes 62,859 51,285 110,433 96,454  
Net revenues 357,759 327,315 697,139 648,709  
Depreciation and amortization 27,760 28,255 54,871 57,013  
Total long-lived assets 307,921   307,921   $ 305,761
United States          
Segment Reporting [Line Items]          
Total net revenues 267,807 240,089      
Net revenues     525,651 482,493  
Total long-lived assets 228,410   228,410   224,699
Japan          
Segment Reporting [Line Items]          
Total net revenues 16,092 18,011      
Net revenues     28,950 31,659  
Total long-lived assets 817   817   916
Europe          
Segment Reporting [Line Items]          
Total net revenues 46,611 42,965      
Net revenues     92,140 83,847  
Total long-lived assets 31,784   31,784   32,080
Rest of Asia          
Segment Reporting [Line Items]          
Total net revenues 23,663 22,567      
Net revenues     43,826 44,215  
Total long-lived assets 29,712   29,712   30,833
Other          
Segment Reporting [Line Items]          
Total net revenues 3,586 3,683      
Net revenues     6,572 6,495  
Total long-lived assets 17,198   17,198   17,233
Apheresis          
Segment Reporting [Line Items]          
Total net revenues 204,805 181,818 396,123 363,554  
Net revenues 204,805 181,818 396,123 363,554  
Depreciation and amortization 13,978 13,882 27,609 27,794  
Total long-lived assets 246,068   246,068   246,042
Apheresis | Plasma          
Segment Reporting [Line Items]          
Net revenues 162,584 139,614 318,108 284,688  
Apheresis | Other          
Segment Reporting [Line Items]          
Net revenues 42,221 42,204 78,015 78,866  
MedSurg          
Segment Reporting [Line Items]          
Total net revenues 152,954 145,497 301,016 285,155  
Net revenues 152,954 145,497 301,016 285,155  
Depreciation and amortization 13,782 14,373 27,262 29,219  
Total long-lived assets 61,853   61,853   $ 59,719
MedSurg | Interventional Technologies          
Segment Reporting [Line Items]          
Net revenues 60,508 59,073 120,450 117,556  
MedSurg | Blood Management Technologies          
Segment Reporting [Line Items]          
Net revenues 92,446 86,424 180,566 167,599  
Operating Segments | Apheresis          
Segment Reporting [Line Items]          
Cost of goods sold 88,456 79,967 172,587 155,832  
Selling, general and administrative 47,303 38,265 91,567 78,145  
Research and development 6,647 6,170 13,025 12,986  
Operating income 62,399 57,416 118,944 116,591  
Operating Segments | MedSurg          
Segment Reporting [Line Items]          
Cost of goods sold 47,673 49,318 98,041 99,534  
Selling, general and administrative 63,770 57,966 128,930 120,289  
Research and development 9,854 8,352 19,674 17,094  
Operating income 31,657 29,861 54,371 48,238  
Corporate          
Segment Reporting [Line Items]          
Operating income 75,120 58,491 132,578 112,363  
Amortization of acquired assets 10,403 13,237 20,607 27,065  
Integration and transaction costs (2,551) (1,520) (5,317) (4,202)  
Restructuring and restructuring related costs (215) 258 2,043 1,582  
Digital transformation costs 5,405 5,054 11,568 10,409  
Other $ (792) $ (8,717) $ (1,202) $ (9,208)